Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Human Reproduction (Oxford, England)
|
March 21, 2026
A clinical protocol for the detection of comorbidities associated with monogenic causes of male infertility
G W van der Heijden, D Westra, M C S van Olden, et al.
Clinical Chemistry and Laboratory Medicine
|
June 14, 2024
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients
Charissa Wijnands, Gad Armony, Somayya Noori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination
Sasja F Mulder, Joannes F M Jacobs, Michel A M Olde Nordkamp, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer
John Dulos, Gregory J Carven, Susan J van Boxtel, et al.
Cancer Immunology, Immunotherapy : CII
|
April 25, 2012
Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
Erik H J G Aarntzen, I Jolanda M de Vries, Joop H Göertz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2006
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
W J Lesterhuis, I J M de Vries, D H Schuurhuis, et al.
Clinical Chemistry and Laboratory Medicine
|
January 2, 2026
Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan
Saskia M C Langemeijer, Jeroen D Langereis, Mendy Ter Avest, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2008
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
A C Inge Boullart, Erik H J G Aarntzen, Pauline Verdijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2012
Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients
Erik H J G Aarntzen, Gerty Schreibelt, Kalijn Bol, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2011
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging
Erik H J G Aarntzen, Mangala Srinivas, Johannes H W De Wilt, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Human Reproduction (Oxford, England)
|
March 21, 2026
A clinical protocol for the detection of comorbidities associated with monogenic causes of male infertility
G W van der Heijden, D Westra, M C S van Olden, et al.
Clinical Chemistry and Laboratory Medicine
|
June 14, 2024
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients
Charissa Wijnands, Gad Armony, Somayya Noori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination
Sasja F Mulder, Joannes F M Jacobs, Michel A M Olde Nordkamp, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer
John Dulos, Gregory J Carven, Susan J van Boxtel, et al.
Cancer Immunology, Immunotherapy : CII
|
April 25, 2012
Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
Erik H J G Aarntzen, I Jolanda M de Vries, Joop H Göertz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2006
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
W J Lesterhuis, I J M de Vries, D H Schuurhuis, et al.
Clinical Chemistry and Laboratory Medicine
|
January 2, 2026
Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan
Saskia M C Langemeijer, Jeroen D Langereis, Mendy Ter Avest, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2008
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
A C Inge Boullart, Erik H J G Aarntzen, Pauline Verdijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2012
Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients
Erik H J G Aarntzen, Gerty Schreibelt, Kalijn Bol, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2011
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging
Erik H J G Aarntzen, Mangala Srinivas, Johannes H W De Wilt, et al.
Page
of 11